Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4OTK

A structural characterization of the isoniazid Mycobacterium tuberculosis drug target, Rv2971, in its unliganded form

4OTK の概要
エントリーDOI10.2210/pdb4otk/pdb
分子名称Mycobacterial Enzyme Rv2971, MALONATE ION, CHLORIDE ION, ... (4 entities in total)
機能のキーワードtim barrel, oxidoreductase
由来する生物種Mycobacterium tuberculosis
タンパク質・核酸の鎖数1
化学式量合計34427.69
構造登録者
Shahine, A.,Beddoe, T. (登録日: 2014-02-13, 公開日: 2014-05-07, 最終更新日: 2023-11-08)
主引用文献Shahine, A.,Prasetyoputri, A.,Rossjohn, J.,Beddoe, T.
A structural characterization of the isoniazid Mycobacterium tuberculosis drug target, Rv2971, in its unliganded form
Acta Crystallogr.,Sect.F, 70:572-577, 2014
Cited by
PubMed Abstract: Aldo-keto reductases (AKR) are a large superfamily of NADPH-dependent oxidoreductases and play a role in detoxification of toxic metabolites. Rv2971, an AKR in Mycobacterium tuberculosis, has recently been identified as a target of isoniazid, a key first-line drug against tuberculosis. Here, the cloning, expression, purification, crystallization and structural characterization of Rv2971 are described. To gain insight into its function, the crystal structure of Rv2971 was successfully determined to 1.60 Å resolution in its unliganded form. The structure exhibits a TIM-barrel fold typical of AKRs, revealing structural characteristics essential for function and substrate specificities, allowing a structural comparison between Rv2971 and other mycobacterial AKRs.
PubMed: 24817712
DOI: 10.1107/S2053230X14007158
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.6 Å)
構造検証レポート
Validation report summary of 4otk
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon